Victory Capital Management Inc Abcam PLC Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 06, 2023	SELL	$21.54 - $24.41 $8.25 Million - $9.35 Million	-382,974 Reduced 29.91%	897,419 $20.3 Million
Q2 2023 Jul 27, 2023	SELL	$12.62 - $24.47 $377,565 - $732,093	-29,918 Reduced 2.28%	1,280,393 $31.3 Million
Q1 2023 May 02, 2023	BUY	$12.98 - $17.1 $533,010 - $702,194	41,064 Added 3.24%	1,310,311 $17.6 Million
Q4 2022 Feb 09, 2023	BUY	$13.92 - $17.0 $17.7 Million - $21.6 Million	1,269,247 New	1,269,247 $19.7 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.